Pyxis Oncology, Inc. (PYXS)
$1.84
Pyxis Oncology, Inc. (PYXS) Share Price Forecast
Currently 10 wall-street analysts regularly analyze the financials of Pyxis Oncology, Inc. on a frequent basis to provide recommendations along with target share price. 10 analysts offering 12-month price forecasts for Pyxis Oncology, Inc. (PYXS) have a share price target of $8.67. This median of share price forecast represents a 371.2% upside from the latest price of $1.84 as on 28.09.23.
Pyxis Oncology, Inc. (PYXS) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Pyxis Oncology, Inc. (PYXS) share price will touch around $8.67 in next 12-months.
Pyxis Oncology, Inc. (PYXS) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Pyxis Oncology, Inc.'s share price and its median forecast price. As on 28.09.23, the difference is -73.24%
Pyxis Oncology, Inc. (PYXS): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Pyxis Oncology, Inc. (PYXS) Share Price : Analyst Recommendation
Based on 10 analysts tracking and researching Pyxis Oncology, Inc. (PYXS) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 5 | 5 | 4 |
| Outperform | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Pyxis Oncology, Inc. (PYXS) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Pyxis Oncology, Inc. (PYXS) is $8.67, offered by 10 analysts offering 12-month price forecasts.
Pyxis Oncology, Inc. (PYXS) has a maximum of 3.71 upside potential, based on 10 analysts offering 12-month price forecasts.
Based on 10 analysts tracking and researching Pyxis Oncology, Inc. (PYXS), 80% have a buy recommendation. Remaining 20% have either sell or hold recommendations.
The latest share price of Pyxis Oncology, Inc. (PYXS) is $1.84 as of 28/09/2023.
8 of total 10 analysts offering stock ratings for Pyxis Oncology, Inc. PYXS have recommended buy rating.
₹0 US Stocks a/c Opening Fee